Zdrowie i gospodarka · 29/05/2008

FDA Proposes Changes to Labeling for Human Prescription Drugs and Biological Products During Pregnancy and Lactation

The FDA is proposing changes to the labeling of human prescription drugs and biological products, specifically the 'Pregnancy', 'Labor and delivery', and 'Nursing mothers' sections, to provide clearer information about the risks of using these drugs during pregnancy and lactation. The proposed rule aims to create a consistent format for providing this information, which will be useful for healthcare providers and women of childbearing age.